Latest Insider Transactions at Humanigen, Inc (HGEN)
This section provides a real-time view of insider transactions for Humanigen, Inc (HGEN). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of HUMANIGEN, INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of HUMANIGEN, INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 29
2019
|
Rainer J. Boehm |
BUY
Grant, award, or other acquisition
|
Direct |
238,625
+42.93%
|
$0
$0.66 P/Share
|
|
May 14
2019
|
Robert G. Savage |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+33.35%
|
$0
$0.66 P/Share
|
|
Apr 23
2019
|
Cameron Durrant Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
75,000
+19.3%
|
$0
$0.66 P/Share
|
|
Mar 29
2019
|
Rainer J. Boehm |
BUY
Grant, award, or other acquisition
|
Direct |
12,222
+13.46%
|
$12,222
$1.35 P/Share
|
|
Mar 29
2019
|
Robert G. Savage |
BUY
Grant, award, or other acquisition
|
Direct |
13,704
+12.07%
|
$13,704
$1.35 P/Share
|
|
Mar 29
2019
|
Ronald Barliant |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+5.55%
|
$10,000
$1.35 P/Share
|
|
Mar 08
2019
|
Cameron Durrant Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
75,000
+23.92%
|
$0
$0.66 P/Share
|
|
Jan 03
2019
|
Ronald Barliant |
BUY
Grant, award, or other acquisition
|
Direct |
18,243
+10.23%
|
$0
$0.74 P/Share
|
|
Jan 03
2019
|
Rainer J. Boehm |
BUY
Grant, award, or other acquisition
|
Direct |
18,243
+21.57%
|
$0
$0.74 P/Share
|
|
Jan 03
2019
|
Robert G. Savage |
BUY
Grant, award, or other acquisition
|
Direct |
20,946
+19.56%
|
$0
$0.74 P/Share
|
|
Dec 14
2018
|
Cameron Durrant Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,000
+2.39%
|
$0
$0.82 P/Share
|
|
Dec 12
2018
|
Cameron Durrant Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,000
+1.24%
|
$0
$0.82 P/Share
|
|
Dec 11
2018
|
Cameron Durrant Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+1.56%
|
$0
$0.76 P/Share
|
|
Dec 10
2018
|
Cameron Durrant Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+1.59%
|
$0
$0.75 P/Share
|
|
Dec 07
2018
|
Cameron Durrant Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,000
+4.39%
|
$0
$0.74 P/Share
|
|
Dec 06
2018
|
Cameron Durrant Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+6.43%
|
$0
$0.73 P/Share
|
|
Sep 28
2018
|
Robert G. Savage |
BUY
Grant, award, or other acquisition
|
Direct |
24,219
+27.08%
|
$0
$0.64 P/Share
|
|
Sep 28
2018
|
Ronald Barliant |
BUY
Grant, award, or other acquisition
|
Direct |
21,094
+12.94%
|
$0
$0.64 P/Share
|
|
Sep 28
2018
|
Rainer J. Boehm |
BUY
Grant, award, or other acquisition
|
Direct |
21,094
+30.49%
|
$0
$0.64 P/Share
|
|
Aug 07
2018
|
Ronald Barliant |
BUY
Grant, award, or other acquisition
|
Direct |
27,000
+18.27%
|
$0
$0.5 P/Share
|
|
Aug 07
2018
|
Robert G. Savage |
BUY
Grant, award, or other acquisition
|
Direct |
31,000
+43.06%
|
$0
$0.5 P/Share
|
|
Aug 07
2018
|
Rainer J. Boehm |
BUY
Grant, award, or other acquisition
|
Direct |
27,000
+50.0%
|
$0
$0.5 P/Share
|
|
Feb 27
2018
|
Nomis Bay Ltd. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
29,893,424
+47.1%
|
$0
$0.28 P/Share
|
|
Feb 27
2018
|
Dale Chappell Chief Scientific Officer |
BUY
Open market or private purchase
|
Indirect |
32,028,669
+40.59%
|
$0
$0.09 P/Share
|
|
Feb 27
2018
|
Dale Chappell Chief Scientific Officer |
BUY
Other acquisition or disposition
|
Indirect |
29,893,424
+46.16%
|
-
|
|
Aug 30
2017
|
Nomis Bay Ltd. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
38,900
-1.05%
|
$0
$0.46 P/Share
|
|
Aug 26
2016
|
Martin Shkreli > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
309,723
-100.0%
|
$929,169
$3.1 P/Share
|
|
Aug 25
2016
|
Martin Shkreli > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
1,913,206
-86.07%
|
$5,739,618
$3.1 P/Share
|
|
Jun 30
2016
|
Ronald Barliant |
BUY
Grant, award, or other acquisition
|
Direct |
93,786
+50.0%
|
-
|
|
Jun 30
2016
|
Cameron Durrant Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
135,583
+50.0%
|
-
|
|
Dec 16
2015
|
Michael Wayne Harrison Director |
BUY
Open market or private purchase
|
Direct |
1,705
+50.0%
|
$49,445
$29.32 P/Share
|
|
Dec 16
2015
|
Marek Biestek Director |
BUY
Open market or private purchase
|
Direct |
10,000
+3.85%
|
$290,000
$29.32 P/Share
|
|
Dec 16
2015
|
Thomas Edward Fernandez Director |
BUY
Open market or private purchase
|
Direct |
6,821
+50.0%
|
$197,809
$29.32 P/Share
|
|
Dec 16
2015
|
Anthion Partners Ii LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
3,410
+0.89%
|
$98,890
$29.32 P/Share
|
|
Dec 16
2015
|
Anthion Partners Ii LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
3,410
+0.89%
|
$98,890
$29.32 P/Share
|
|
Nov 24
2015
|
Martin Shkreli > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
5,000
+0.24%
|
$190,000
$38.15 P/Share
|
|
Nov 20
2015
|
Martin Shkreli > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
5,000
+0.24%
|
$90,000
$18.88 P/Share
|
|
Nov 18
2015
|
Martin Shkreli > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
440,000
+17.56%
|
$880,000
$2.02 P/Share
|
|
Nov 18
2015
|
Marek Biestek Director |
BUY
Open market or private purchase
|
Direct |
40,000
+14.29%
|
$80,000
$2.04 P/Share
|
|
Nov 18
2015
|
Anthion Partners Ii LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
150,000
+20.7%
|
$300,000
$2.13 P/Share
|
|
Nov 18
2015
|
Anthion Partners Ii LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
150,000
+20.7%
|
$300,000
$2.13 P/Share
|
|
Nov 17
2015
|
Marek Biestek Director |
BUY
Open market or private purchase
|
Direct |
135,000
+40.3%
|
$135,000
$1.83 P/Share
|
|
Nov 17
2015
|
Martin Shkreli > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
613,677
+13.85%
|
$1,227,354
$2.18 P/Share
|
|
Nov 17
2015
|
Anthion Partners Ii LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
113,800
+21.13%
|
$113,800
$1.69 P/Share
|
|
Nov 17
2015
|
Anthion Partners Ii LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
113,800
+21.13%
|
$113,800
$1.69 P/Share
|
|
Nov 16
2015
|
Marek Biestek Director |
BUY
Open market or private purchase
|
Direct |
65,000
+50.0%
|
$65,000
$1.36 P/Share
|
|
Nov 16
2015
|
Martin Shkreli > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
597,438
+22.07%
|
$597,438
$1.02 P/Share
|
|
Nov 16
2015
|
Anthion Partners Ii LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
243,063
+24.34%
|
$243,063
$1.51 P/Share
|
|
Nov 16
2015
|
Anthion Partners Ii LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
243,063
+24.34%
|
$243,063
$1.51 P/Share
|
|
Feb 05
2013
|
Dennis Henner Director |
BUY
Conversion of derivative security
|
Indirect |
2,632,928
+24.79%
|
-
|